$0.53
0.66% today
Nasdaq, Sep 16, 08:49 pm CET
ISIN
US6901451079
Symbol
OM

Outset Medical Inc Stock price

$0.53
-0.34 39.08% 1M
-1.90 78.19% 6M
-4.88 90.20% YTD
-12.32 95.88% 1Y
-49.18 98.93% 3Y
-60.15 99.13% 5Y
-60.15 99.13% 10Y
Nasdaq, Closing price Fri, Sep 13 2024
+0.08 17.67%
ISIN
US6901451079
Symbol
OM
Sector

Key metrics

Market capitalization $27.61m
Enterprise Value $35.06m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.30
P/S ratio (TTM) P/S ratio 0.24
P/B ratio (TTM) P/B ratio 0.40
Revenue growth (TTM) Revenue growth -9.94%
Revenue (TTM) Revenue $116.43m
EBIT (operating result TTM) EBIT $-150.48m
Free Cash Flow (TTM) Free Cash Flow $-140.00m
Cash position $194.85m
EPS (TTM) EPS $-3.14
P/E forward negative
P/S forward 0.25
EV/Sales forward 0.32
Short interest 8.77%
Show more

Is Outset Medical Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Outset Medical Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Outset Medical Inc forecast:

4x Buy
50%
3x Hold
38%
1x Sell
13%

Analyst Opinions

8 Analysts have issued a Outset Medical Inc forecast:

Buy
50%
Hold
38%
Sell
13%

Financial data from Outset Medical Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '23
+/-
%
130 130
13% 13%
100%
- Direct Costs 101 101
4% 4%
78%
29 29
63% 63%
22%
- Selling and Administrative Expenses 136 136
10% 10%
104%
- Research and Development Expense 57 57
17% 17%
44%
-164 -164
6% 6%
-126%
- Depreciation and Amortization 5.81 5.81
7% 7%
4%
EBIT (Operating Income) EBIT -170 -170
5% 5%
-130%
Net Profit -173 -173
6% 6%
-133%

In millions USD.

Don't miss a Thing! We will send you all news about Outset Medical Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Outset Medical Inc Stock News

Neutral
PRNewsWire
about 18 hours ago
NEW YORK , Sept. 15, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outset Medical, Inc. (NASDAQ: OM) between August 1, 2022 and August 7, 2024, both dates inclusive (the "Class Period") of the important October 28, 2024 lead plaintiff deadline.
Neutral
PRNewsWire
3 days ago
LOS ANGELES , Sept. 13, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM).
Neutral
Accesswire
5 days ago
SAN FRANCISCO, CA / ACCESSWIRE / September 11, 2024 / Hagens Berman encourages Outset Medical (NASDAQ:OM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys.
More Outset Medical Inc News

Company Profile

Outset Medical, Inc. is a medical technology company, which provides dialysis solutions to patients and healthcare providers. Its product Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.

Head office United States
CEO Leslie Trigg
Employees 480
Founded 2003
Website www.outsetmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today